Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine

Artificial intelligence (AI) and nanotechnology are two fields that are instrumental in realizing the goal of precision medicine-tailoring the best treatment for each cancer patient. Recent conversion between these two fields is enabling better patient data acquisition and improved design of nanomaterials for precision cancer medicine. Diagnostic nanomaterials are used to assemble a patient-specific disease profile, which is then leveraged, through a set of therapeutic nanotechnologies, to improve the treatment outcome. However, high intratumor and interpatient heterogeneities make the rational design of diagnostic and therapeutic platforms, and analysis of their output, extremely difficult. Integration of AI…

• GF
  German-Israeli Foundation for Scientific Research and Development

  Award: I‐2328‐1139.10/2012
• IC
  Israel Cancer Association

  Award: 2015‐0116
• IS
  Israel Science Foundation

  Awards: 1778/13, 1421/17
• LI
  Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion-Israel Institute of Technology
• MO
  Ministry of Science and Technology, Israel

  Award: 3‐11878
• MO
  Ministry of Economy

  Award: 52752
• RB
  Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology
• PR
  Phospholipid Research Center
• ER
  European Research Council

  Award: STG‐2015‐680242
• FS
  FP7 Science in Society

  Award: 908049